MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.heliyon.2022.e11248

Медицинская библиотека · Heliyon · 2022

Spontaneous bacterial peritonitis in hepatocellular carcinoma after PD-1 inhibitor therapy: two clinical cases.

Liu Jianwei, Xue Hui, Bai Shilei, Wang Jie, Zhang Yue, Liu Liu, Zhang Lei, Yang Zhao, KuiWang

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

With the recent advances in immunotherapy, especially programmed cell death protein 1 (PD-1) inhibitors, the treatment of hepatocellular carcinoma (HCC) patients has entered a new stage. However, few reports have focused on spontaneous bacterial peritonitis (SBP) after PD-1 inhibitor treatment of intermediate-to advanced-stage HCC. In this article, we report two clinical cases of SBP after successful PD-1 inhibitor therapy. The patient's condition was assessed as a complete response (CR) according to the mRECIST criteria. Based on these two cases, we found that patients with large or giant HCC who have large tumour diameter should be closely monitored for SBP after successful PD-1 inhibitor therapy, especially when the imaging shows the rapid development of marked necrosis and depression at the tumour site. Early and active treatment is necessary to reduce the suffering caused by SBP.

Для цитирования: Liu Jianwei, Xue Hui, Bai Shilei, Wang Jie, Zhang Yue, Liu Liu, Zhang Lei, Yang Zhao, KuiWang. Spontaneous bacterial peritonitis in hepatocellular carcinoma after PD-1 inhibitor therapy: two clinical cases.. Heliyon. 2022. DOI: 10.1016/j.heliyon.2022.e11248.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.